PACB
NASDAQ · Life Sciences Tools & Services
Pacific Biosciences Of Calif
$1.33
-0.07 (-5.00%)
Analyst Consensus
Buy
16
Analysts
High
Coverage
Price Target
Analyst Price Target
+3,426.3% upside
Low Target
$34.06
Average Target
$46.90
High Target
$60.93
Current Price
$1.33
Current
$1.33
$1.33
Target
$46.90
$46.90
$34.06
$46.90 avg
$60.93
Scenario Analysis
Bear Case
$34.06
2,460.9%
Low target
Base Case
$46.90
+3,426.3%
Avg target
Bull Case
$60.93
+4,481.2%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$2.73
-51.3% from high
52-Week Low
$0.85
+56.3% from low
Target vs 52W High
$46.90
+1,617.9% vs high
Next Earnings Report
Apr 7, 2026
11d
until earnings
EPS Est: $-0.11
Earnings in 11 days. Analyst targets may shift significantly after the report.
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 33 | 88% | $369.21 | -24.8% |
| DHR | Strong Buy | 30 | 87% | $158.11 | -15.5% |
| A | Buy | 29 | 72% | $64.69 | -42.7% |
| IQV | Strong Buy | 30 | 80% | $82.96 | -49.9% |
| MTD | Hold | 21 | 43% | $170.43 | -86.5% |
| ILMN | Hold | 28 | 54% | $169.36 | +34.2% |
| WAT | Buy | 28 | 57% | $189.60 | -37.3% |
| WST | Strong Buy | 23 | 78% | $136.24 | -44.8% |